Event Schedule

Have a look at Schedule

08:00

Registration & Itinerary Collection

08:50

Welcome Remarks from World BI

Amraj Dhillon

Key Account Manager

World BI
08:55

Chairperson Welcome Address

Isabelle Naëije, PMP

Assoc. Global Trial Director

Novartis
09:00

Presentation 1: Maintenance of ethical balance between research strategy and clinical trial efficacy

Tali Schaffer

Exe. Director (develop treatments to neometals)

ELGAN Pharma
09:25

Presentation 2: Concept of smart trials: New technique to optimize clinical studies

09:50

Interactive Discussion: Redesigning the Clinical Research Environment

Panelists:

Isabelle Naëije, PMP

Assoc. Global Trial Director

Novartis

Dr. Andriy Krendyukov

VP Medical Affairs

10:20

Coffee Break & Networking Session

11:10

Presentation 3: Patient represent the "last mile of knowledge" to improve clinical outcomes


  • Sensitivity and knowledge when it comes to patients
  • The 'Modern Role' of patient in the Healthcare System
  • Rethink Patient Journey in a 360° holistic view

Andrea Forgione, HSBA

Global Lead, Patient Engagement & Advocacy - Owner of Global Trasparency Process

MENARINI Group
11:35

Presentation 4: Guiding Clinical Research by Involving Patients from A to Z, to improve quality and success

Francois Houyez

Treatment Information and Access Director / Health Policy Advisor

European Organisation for Rare Diseases (Eurordis)
12:00

Presentation 5: Improving patient engagement by reducing barriers in clinical trials

12:25

Presentation 6: Regulatory Guidelines for Patient Data Transparency in Clinical Trials

Dr Solange Corriol-Rohou, MD

Senior Director Regulatory Affairs & Policy, Europe

AstraZeneca
12:55

Lunch Break

13:55

Fire Side Chat: Clinical Operations 3.0….What will Clinical Operations look like in the year 2050

Moderator

Bernhard Glombitza

Head Clinical Operations EMEA & APAC, VP

Bayer Pharmaceuticals

Panelist:-

Jessica Cordes

Senior Clinical Operations Expert

14:35

Presentation 7: Clinical trials with cell and gene therapy along with key operational elements and best practises

Jessica Cordes

Senior Clinical Operations Expert

15:00

Presentation 8: GCP (Good Clinical Practices) Quality and Risks in Decentralized Clinical Trials

Konstantinos Tsekmes

Associate Director Clinical Operations

MSD
15:25

Coffee Break & Networking Session

16:15

Interactive Discussion: Rare diseases and decentralized clinical trials

Moderator:-

Dr Solange Corriol-Rohou, MD

Senior Director Regulatory Affairs & Policy, Europe

AstraZeneca

Panelist:-

Dr. Andriy Krendyukov

VP Medical Affairs

16:45

Presentation 9: The era of Precision Medicine for clinical oncology trials: Current Context, Best Operational Practices

Dr. Harsha Doddihal

Vice President Clinical Development

Glenmark Pharmaceuticals
17:05

Interactive Discussion: Decentralized Clinical Trials or AI in clinical trials?

Isabela Niculae, MPH

Head Global Clinical Sciences & Operations Innovation

UCB
17:35

Chair Closing Remarks

Isabelle Naëije, PMP

Assoc. Global Trial Director

Novartis
17:40

End of Day 1

08:00

Registration & Itinerary Collection

08:50

Welcome Remarks from World BI

Amraj Dhillon

Key Account Manager

World BI
08:55

Chair Welcome Address

09:00

Presentation 10: Clinical Trials in oncology: Practice-Changing, Landmark Studies with an Emphasis on More Recent Trials

Dr. Ravit Geva

Medical Oncology specialist, Head, GIT malignancies Center, Head, Research Unit, Deputy Director Division of Oncology

Tel Aviv Sourasky Medical Center
09:25

Presentation 11: The Use of Telemedicine in Cancer Clinical Trials

Antonella Cardone

Chief Executive Officer

Cancer Patients Europe - CPE
09:50

Presentation 12: Clinical document templates to make studies more patients centric and other tools to assess and reduce patient burden

Nikita Sharma

Global Clinical Sciences & Operations Innovation Manager

UCB
10:15

Coffee Break & Networking Session

11:05

Presentation 13: Clinical-Tech: a computerized system for using administrative data for clinical trials quality assurance

Seif eddine AMARA MADI

Director Clinical Labs Quality

GSK Biopharma
11:30

Presentation 14: Data management and Data-processing strategies in oncology

Swapna Pothula (TBC)

PMP, Associate Director - Asset Data Management Quality Lead

GSK
11:55

Presentation 15: Strategies involved in clinical trial data management

Giacomo Ricca (TBC)

Lead Data Processing Solutions

The Janssen Pharmaceutical Companies of Johnson & Johnson
12:20

Presentation 16: Innovation in the management of clinical data, a futuristic outlook

Dr. Jose Manuel Cervera Grau

Executive Director

Eli Lilly
12:45

Lunch Break

13:45

Presentation 17: The importance of diversity in clinical trials

Miki Olshansky

Founder & CEO

Elgan Pharma
14:10

Presentation 18: Translating innovation in research methods to deliver clinical trials: a case study in Axoltis’ NX210c

Annette Janus, MD

Chief Medical Officer

Axoltis Pharma
14:35

Presentation 18: TBC

Niyati Prasad (TBC)

Chief Medical Officer

Enterprise Therapeutics
15:00

Interactive Discussion: How quickly is the clinical trials market in Europe is expanding?

15:30

Chair Closing Remarks

15:45

End of Day 2